RU2017101102A - Способы лечения зуда - Google Patents
Способы лечения зуда Download PDFInfo
- Publication number
- RU2017101102A RU2017101102A RU2017101102A RU2017101102A RU2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A RU 2017101102 A RU2017101102 A RU 2017101102A
- Authority
- RU
- Russia
- Prior art keywords
- paragraphs
- subject
- antipruritic agent
- dose
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462011936P | 2014-06-13 | 2014-06-13 | |
| US62/011,936 | 2014-06-13 | ||
| PCT/US2015/035650 WO2015192071A1 (en) | 2014-06-13 | 2015-06-12 | Methods for treating pruritus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2017101102A true RU2017101102A (ru) | 2018-07-16 |
| RU2017101102A3 RU2017101102A3 (enExample) | 2019-01-28 |
Family
ID=54834447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017101102A RU2017101102A (ru) | 2014-06-13 | 2015-06-12 | Способы лечения зуда |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20150359789A1 (enExample) |
| EP (1) | EP3154546A4 (enExample) |
| JP (1) | JP2017517553A (enExample) |
| KR (1) | KR20170016983A (enExample) |
| CN (1) | CN106535897A (enExample) |
| AU (1) | AU2015274327A1 (enExample) |
| BR (1) | BR112016029236A2 (enExample) |
| CA (1) | CA2951420A1 (enExample) |
| IL (1) | IL249475A0 (enExample) |
| MX (1) | MX2016016404A (enExample) |
| RU (1) | RU2017101102A (enExample) |
| WO (1) | WO2015192071A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| US20170216277A1 (en) * | 2016-01-06 | 2017-08-03 | Trevi Therapeutics, Inc. | Therapeutic use of nalbuphine without aquaretic effects |
| AU2017238051B9 (en) * | 2016-03-21 | 2022-11-03 | Trevi Therapeutics, Inc. | Treatment of uremic pruritus |
| BR112019008241A2 (pt) * | 2016-10-25 | 2019-07-16 | Trevi Therapeutics Inc | tratamento do prurigo nodular |
| CN112040948A (zh) * | 2018-03-29 | 2020-12-04 | 顺天医药生技股份有限公司 | 治疗瘙痒的组合物和方法 |
| CN112672743A (zh) * | 2018-07-11 | 2021-04-16 | 特雷维治疗股份有限公司 | 肝病瘙痒症状的治疗 |
| IL318587A (en) * | 2018-07-23 | 2025-03-01 | Trevi Therapeutics Inc | Treatment of chronic cough, shortness of breath and wheezing |
| IL294601A (en) | 2020-01-10 | 2022-09-01 | Trevi Therapeutics Inc | Methods of administration of nalbuphine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8394812B2 (en) * | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
| PT1931315E (pt) * | 2005-08-24 | 2014-01-03 | Endo Pharmaceuticals Inc | Formulações de libertação sustentada de nalbufina |
| EP2150247B1 (en) * | 2007-04-23 | 2012-10-31 | Symrise AG | Polyethylene glycol esters and cosmetic and/or dermatological preparations |
| US8987289B2 (en) * | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| US20140179727A1 (en) * | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| US8637538B1 (en) * | 2012-12-14 | 2014-01-28 | Trevi Therapeutics, Inc. | Methods for treatment of pruritis |
| EP2931279B1 (en) * | 2012-12-14 | 2024-03-20 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
-
2015
- 2015-06-12 CN CN201580039250.9A patent/CN106535897A/zh active Pending
- 2015-06-12 WO PCT/US2015/035650 patent/WO2015192071A1/en not_active Ceased
- 2015-06-12 JP JP2016572657A patent/JP2017517553A/ja active Pending
- 2015-06-12 KR KR1020177001115A patent/KR20170016983A/ko not_active Withdrawn
- 2015-06-12 AU AU2015274327A patent/AU2015274327A1/en not_active Abandoned
- 2015-06-12 EP EP15807379.1A patent/EP3154546A4/en not_active Withdrawn
- 2015-06-12 RU RU2017101102A patent/RU2017101102A/ru not_active Application Discontinuation
- 2015-06-12 CA CA2951420A patent/CA2951420A1/en not_active Abandoned
- 2015-06-12 US US14/738,550 patent/US20150359789A1/en not_active Abandoned
- 2015-06-12 BR BR112016029236A patent/BR112016029236A2/pt not_active Application Discontinuation
- 2015-06-12 MX MX2016016404A patent/MX2016016404A/es unknown
-
2016
- 2016-12-11 IL IL249475A patent/IL249475A0/en unknown
-
2018
- 2018-04-30 US US15/966,850 patent/US20190099416A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN106535897A (zh) | 2017-03-22 |
| RU2017101102A3 (enExample) | 2019-01-28 |
| EP3154546A4 (en) | 2018-01-10 |
| US20150359789A1 (en) | 2015-12-17 |
| KR20170016983A (ko) | 2017-02-14 |
| MX2016016404A (es) | 2017-11-30 |
| EP3154546A1 (en) | 2017-04-19 |
| WO2015192071A1 (en) | 2015-12-17 |
| AU2015274327A1 (en) | 2017-01-05 |
| CA2951420A1 (en) | 2015-12-17 |
| IL249475A0 (en) | 2017-02-28 |
| US20190099416A1 (en) | 2019-04-04 |
| BR112016029236A2 (pt) | 2017-11-07 |
| JP2017517553A (ja) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017101102A (ru) | Способы лечения зуда | |
| RU2015128265A (ru) | Способы лечения зуда | |
| JP2016506398A5 (enExample) | ||
| JP2017517553A5 (enExample) | ||
| US20240245646A1 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| DD244293A5 (de) | Verfahren zur herstellung eines arzneimittels | |
| JP2019131588A5 (ja) | 抗そう痒剤 | |
| AU2017327383A1 (en) | Method of reducing thyroid-associated side effects | |
| JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 | |
| JP2018521047A (ja) | 掻痒の治療 | |
| JP2015519398A5 (enExample) | ||
| JP2019509309A5 (enExample) | ||
| JP2017527627A (ja) | 喫煙者における非小細胞肺癌の治療のための、カルボプラチンおよびパクリタキセルと併用したベリパリブ | |
| WO2010110428A1 (ja) | 掻痒の予防及び／または治療剤 | |
| JP2020514347A (ja) | チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤 | |
| CN114945371A (zh) | 肥大细胞疾病和嗜酸性粒细胞疾病的治疗 | |
| RU2388474C2 (ru) | Применение производного дигидроимидазопиразина для лечения или предупреждения боли | |
| CN112402420A (zh) | 钩吻素子在制备用于治疗炎症性肠病的药物中的用途 | |
| US20240122956A1 (en) | Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia | |
| CN108969523A (zh) | 化合物在制备治疗转移性癌症的药物中的应用 | |
| RU2024111332A (ru) | Ресметиром для уменьшения объема печени | |
| US9284281B2 (en) | Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain | |
| HK40041872A (en) | Method for preventing and/or treating aging-associated cognitive impairment | |
| US20170273931A1 (en) | Composition comprising a compound from the family of avermectins and doxycycline for the treatment of rosacea | |
| WO2021067917A1 (en) | Treatment of eosinophilic disorders with avapritinib |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20190520 |